Search by Drug Name or NDC
NDC 70710-1289-08 Triazolam 0.25 mg/1 Details
Triazolam 0.25 mg/1
Triazolam is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is TRIAZOLAM.
MedlinePlus Drug Summary
Triazolam is used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep). Triazolam is in a class of medications called benzodiazepines. It works by slowing activity in the brain to allow sleep.
Related Packages: 70710-1289-08Last Updated: 02/19/2023
MedLinePlus Full Drug Details: Triazolam
Product Information
| NDC | 70710-1289 |
|---|---|
| Product ID | 70710-1289_4c2fb12f-623b-4dc9-a9e0-7fac953f5cf0 |
| Associated GPIs | |
| GCN Sequence Number | 003694 |
| GCN Sequence Number Description | triazolam TABLET 0.25 MG ORAL |
| HIC3 | H21 |
| HIC3 Description | SEDATIVE-HYPNOTICS - BENZODIAZEPINES |
| GCN | 14280 |
| HICL Sequence Number | 001594 |
| HICL Sequence Number Description | TRIAZOLAM |
| Brand/Generic | Generic |
| Proprietary Name | Triazolam |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Triazolam |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 0.25 |
| Active Ingredient Units | mg/1 |
| Substance Name | TRIAZOLAM |
| Labeler Name | Zydus Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA213003 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70710-1289-08 (70710128908)
| NDC Package Code | 70710-1289-8 |
|---|---|
| Billing NDC | 70710128908 |
| Package | 10 TABLET in 1 BOTTLE (70710-1289-8) |
| Marketing Start Date | 2022-12-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |